×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
BCAS1 Antikörper (N-Term)
Dieses Anti-BCAS1-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von BCAS1 in WB und EIA. Geeignet für Human.
Kurzübersicht für BCAS1 Antikörper (N-Term) (ABIN950616)
Target
Alle BCAS1 Antikörper anzeigen
BCAS1
(Breast Carcinoma Amplified Sequence 1 (BCAS1))
Reaktivität
Alle Reaktivitäten für BCAS1 Antikörper
Human
Wirt
Alle Wirte für BCAS1 Antikörper
Kaninchen
Klonalität
Alle Klonalitäten für BCAS1 Antikörper
Polyklonal
Konjugat
Alle Konjugate für BCAS1 Antikörper
Dieser BCAS1 Antikörper ist unkonjugiert
Applikation
Alle Applikationen für BCAS1 Antikörper
Western Blotting (WB), Enzyme Immunoassay (EIA)
Produktdetails anti-BCAS1 Antikörper
(ausblenden)
Bindungsspezifität
Alle Epitope für BCAS1 Antikörper
AA 1-30, N-Term
Spezifität
This antibody reacts to BCAS1.
Kreuzreaktivität (Details)
Species reactivity (tested):Human.
Aufreinigung
Affinity chromatography on Protein A
Immunogen
KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BCAS1
Isotyp
Ig Fraction
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Format
Liquid
Konzentration
0.25 mg/mL
Buffer
PBS containing 0.09 % (W/V) sodium azide as preservative
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Details zu BCAS1
(ausblenden)
Target
BCAS1
(Breast Carcinoma Amplified Sequence 1 (BCAS1))
Andere Bezeichnung
BCAS1 / NABC1
Hintergrund
This gene resides in a region at 20q13 which is amplified in a variety of tumor types and associated with more aggressive tumor phenotypes. Among the genes identified from this region, it was found to be highly expressed in three amplified breast cancer cell lines and in one breast tumor without amplification at 20q13.2. However, this gene is not in the common region of maximal amplification and its expression was not detected in the breast cancer cell line MCF7, in which this region is highly amplified. Although not consistently expressed, this gene is a candidate oncogene.Synonyms: AIBC1, Breast carcinoma-amplified sequence 1
Gen-ID
8537
NCBI Accession
NP_003648
Zuletzt angesehen
(ausblenden)
Chat with us , powered by LiveChat